Monocacy Therapeutics files Form D for $25,000 SAFE offering
The Delaware biotech, based in Monrovia, Maryland, reported selling $25,000 in securities to a single investor under a Regulation D exemption.
SEC filing
Latest
1 story
Sign inSign in1 story
The Delaware biotech, based in Monrovia, Maryland, reported selling $25,000 in securities to a single investor under a Regulation D exemption.
SEC filing